Business
Press Release Dec 22 2022
Strides Pharma Science Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Receipt of AUD 94 million on account of deferred consideration on the sale of the Company s Australian operations in 2019".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated December 22, 2022, titled \"Receipt of AUD 94 million on account of deferred consideration on the sale of the Company s Australian operations in 2019\". View Attachment","length":387,"tagName":"div"}]